Molecular epidemiology of tuberculosis in Tasmania and genomic characterisation of its first known multi-drug resistant case
Open Access
- 21 February 2018
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 13 (2) , e0192351
Abstract
The origin and spread of tuberculosis (TB) in Tasmania and the types of strains of Mycobacterium tuberculosis complex (MTBC) present in the population are largely unknown. The aim of this study was to perform the first genomic analysis of MTBC isolates from Tasmania to better understand the epidemiology of TB in the state. Whole-genome sequencing was performed on cultured isolates of MTBC collected from 2014–2016. Single-locus variant analysis was applied to determine the phylogeny of the isolates and the presence of drug-resistance mutations. The genomic data were then cross-referenced against public health surveillance records on each of the cases. We determined that 83.3% of TB cases in Tasmania from 2014–2016 occurred in non-Australian born individuals. Two possible TB clusters were identified based on single locus variant analysis, one from November-December 2014 (n = 2), with the second from May-August 2015 (n = 4). We report here the first known isolate of multi-drug resistant (MDR) M. tuberculosis in Tasmania from 2016 for which we established its drug resistance mutations and potential overseas origin. In addition, we characterised a case of M. bovis TB in a Tasmanian-born person who presented in 2014, approximately 40 years after the last confirmed case in the state’s bovids. TB in Tasmania is predominantly of overseas origin with genotypically-unique drug-susceptible isolates of M. tuberculosis. However, the state also exhibits features of TB that are observed in other jurisdictions, namely, the clustering of cases, and drug resistance. Early detection of TB and contact tracing, particularly of overseas-born cases, coordinated with rapid laboratory drug-susceptibility testing and molecular typing, will be essential for Tasmania to reach the World Health Organisation’s TB eradication goals for low-incidence settings.Keywords
Funding Information
- Royal Hobart Hospital Research Foundation (17-104)
- Royal Hobart Hospital Research Foundation (17-104)
This publication has 45 references indexed in Scilit:
- Interpreting whole genome sequencing for investigating tuberculosis transmission: a systematic reviewBMC Medicine, 2016
- Lessons learned during the successful eradication of bovine tuberculosis from AustraliaVeterinary Record, 2015
- Rapid determination of anti-tuberculosis drug resistance from whole-genome sequencesGenome Medicine, 2015
- Phylogenetic lineages of tuberculosis isolates in New Zealand and their association with patient demographicsThe International Journal of Tuberculosis and Lung Disease, 2013
- Whole-genome sequencing to delineate Mycobacterium tuberculosis outbreaks: a retrospective observational studyThe Lancet Infectious Diseases, 2013
- Geneious Basic: An integrated and extendable desktop software platform for the organization and analysis of sequence dataBioinformatics, 2012
- Estimating the Burden of Tuberculosis among Foreign-Born Persons Acquired Prior to Entering the U.S., 2005–2009PLOS ONE, 2011
- Major Mycobacterium tuberculosis Lineages Associate with Patient Country of OriginJournal of Clinical Microbiology, 2009
- Mutations at embB Codon 306 Are an Important Molecular Indicator of Ethambutol Resistance in Mycobacterium tuberculosisAntimicrobial Agents and Chemotherapy, 2009
- Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequenceNature, 1998